- Home
- CLLS vs NETD Comparison
CLLS vs NETD Comparison
Compare CLLS & NETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- NETD
- Stock Information
- Founded
- CLLS 1999
- NETD 2023
- Country
- CLLS France
- NETD United States
- Employees
- CLLS N/A
- NETD N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- NETD
- Sector
- CLLS Health Care
- NETD
- Exchange
- CLLS Nasdaq
- NETD Nasdaq
- Market Cap
- CLLS 299.0M
- NETD 242.3M
- IPO Year
- CLLS 2007
- NETD 2023
- Fundamental
- Price
- CLLS $3.49
- NETD $11.34
- Analyst Decision
- CLLS Buy
- NETD
- Analyst Count
- CLLS 1
- NETD 0
- Target Price
- CLLS $8.00
- NETD N/A
- AVG Volume (30 Days)
- CLLS 212.5K
- NETD 190.3K
- Earning Date
- CLLS 11-03-2025
- NETD 01-01-0001
- Dividend Yield
- CLLS N/A
- NETD N/A
- EPS Growth
- CLLS N/A
- NETD N/A
- EPS
- CLLS N/A
- NETD 0.29
- Revenue
- CLLS $63,438,000.00
- NETD N/A
- Revenue This Year
- CLLS N/A
- NETD N/A
- Revenue Next Year
- CLLS $66.76
- NETD N/A
- P/E Ratio
- CLLS N/A
- NETD $38.49
- Revenue Growth
- CLLS 223.09
- NETD N/A
- 52 Week Low
- CLLS $1.10
- NETD $10.65
- 52 Week High
- CLLS $5.48
- NETD $11.47
- Technical
- Relative Strength Index (RSI)
- CLLS 47.81
- NETD 56.27
- Support Level
- CLLS $3.39
- NETD $11.20
- Resistance Level
- CLLS $5.48
- NETD $11.45
- Average True Range (ATR)
- CLLS 0.38
- NETD 0.02
- MACD
- CLLS -0.10
- NETD 0.01
- Stochastic Oscillator
- CLLS 6.38
- NETD 56.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About NETD Nabors Energy Transition Corp. II
Nabors Energy Transition Corp II is a blank check company.